Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| GHK-Cu | PEG-MGF | |
|---|---|---|
| Category | Growth Factors | Growth Factors |
| Standard Dose | Research indicates 1-2 mg daily via subcutaneous injection, or topical application at 1-3% concentration in cream/serum. | — |
| Timing | Evening administration preferred for skin rejuvenation (aligns with nocturnal repair cycles). Topical can be applied morning and evening. | — |
| Cycle Duration | 8-12 weeks for injectable cycles. Topical use can be ongoing. | — |
| Evidence Level | moderate_human | Preclinical |
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that modulates gene expression affecting 31.2% of human genes. It activates Wnt/beta-catenin signaling for hair follicle growth, stimulates TGF-beta pathway for tissue remodeling, and promotes collagen and glycosaminoglycan synthesis while modulating metalloproteinase activity. The copper ion serves as a cofactor for enzymes essential to wound healing including superoxide dismutase and lysyl oxidase.
Research indicates 1-2 mg daily via subcutaneous injection, or topical application at 1-3% concentration in cream/serum.
Evening administration preferred for skin rejuvenation (aligns with nocturnal repair cycles). Topical can be applied morning and evening.
8-12 weeks for injectable cycles. Topical use can be ongoing.
Pegylated mechano growth factor analog discussed in muscle repair and hypertrophy contexts with limited human evidence.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →